CollPlant and United Therapeutics will work on 3D bioprinting of human kidneys for transplant Bioprinting
CollPlant Biotechnologies and United Therapeutics Corporation are expanding their ongoing collaboration with the exercise by United Therapeutics of its option to cover a second lifesaving organ: human kidneys. United Therapeutics paid CollPlant $3 million for the option exercise.